These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26417840)

  • 1. Accuracy of plasma interleukin-18 and adiponectin concentrations in predicting metabolic syndrome and cardiometabolic disease risk in middle-age Brazilian men.
    de Oliveira A; Hermsdorff HH; Cocate PG; Santos EC; Bressan J; Natali AJ
    Appl Physiol Nutr Metab; 2015 Oct; 40(10):1048-55. PubMed ID: 26417840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of metabolic syndrome in Takayasu arteritis: increased cardiovascular risk and lower adiponectin serum levels.
    da Silva TF; Levy-Neto M; Bonfá E; Pereira RM
    J Rheumatol; 2013 Nov; 40(11):1897-904. PubMed ID: 24037555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced circulating adiponectin levels are associated with the metabolic syndrome independently of obesity, lipid indices and serum insulin levels: a cross-sectional study.
    Ntzouvani A; Fragopoulou E; Panagiotakos D; Pitsavos C; Antonopoulou S
    Lipids Health Dis; 2016 Aug; 15(1):140. PubMed ID: 27567677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipokines demonstrate the interacting influence of central obesity with other cardiometabolic risk factors of metabolic syndrome in Hong Kong Chinese adults.
    Supriya R; Tam BT; Yu AP; Lee PH; Lai CW; Cheng KK; Yau SY; Chan LW; Yung BY; Sheridan S; Siu PM
    PLoS One; 2018; 13(8):e0201585. PubMed ID: 30114249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid accumulation product as a marker of cardiometabolic susceptibility in women with different phenotypes of polycystic ovary syndrome.
    Božić-Antić I; Ilić D; Bjekić-Macut J; Bogavac T; Vojnović-Milutinović D; Kastratovic-Kotlica B; Milić N; Stanojlović O; Andrić Z; Macut D
    Eur J Endocrinol; 2016 Dec; 175(6):551-560. PubMed ID: 27634940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
    Onat A; Hergenç G; Can G; Küçükdurmaz Z
    Obesity (Silver Spring); 2009 Mar; 17(3):564-70. PubMed ID: 19238142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indices of adiposity as predictors of cardiometabolic risk and inflammation in young adults.
    Pourshahidi LK; Wallace JM; Mulhern MS; Horigan G; Strain JJ; McSorley EM; Magee PJ; Bonham MP; Livingstone MB
    J Hum Nutr Diet; 2016 Feb; 29(1):26-37. PubMed ID: 25677964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men.
    Gannagé-Yared MH; Khalife S; Semaan M; Fares F; Jambart S; Halaby G
    Eur J Endocrinol; 2006 Jul; 155(1):167-76. PubMed ID: 16793964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of daily alcohol consumption on serum adiponectin levels in men.
    Makita S; Abiko A; Nagai M; Yonezawa S; Koshiyama M; Ohta M; Nakamura M
    Metabolism; 2013 Mar; 62(3):411-6. PubMed ID: 23036646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of homeostasis model assessment of insulin resistance, adiponectin, and low-grade inflammation with the course of the metabolic syndrome.
    Ding Y; Li S; Ma RL; Guo H; Zhang J; Zhang M; Liu J; Guo S
    Clin Biochem; 2015 May; 48(7-8):503-7. PubMed ID: 25700597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifestyle variables, non-traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population.
    Liu J; Young TK; Zinman B; Harris SB; Connelly PW; Hanley AJ
    Obesity (Silver Spring); 2006 Mar; 14(3):500-8. PubMed ID: 16648622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further inflammatory information on metabolic syndrome by adiponectin evaluation.
    Matsushita K; Tamakoshi K; Yatsuya H; Wada K; Otsuka R; Takefuji S; Hotta Y; Kondo T; Murohara T; Toyoshima H
    Int J Cardiol; 2008 Mar; 124(3):339-44. PubMed ID: 17433469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the association of leptin and adiponectin concentrations with metabolic syndrome in children: Results from the IDEFICS study.
    Nappo A; González-Gil EM; Ahrens W; Bammann K; Michels N; Moreno LA; Kourides Y; Iacoviello L; Mårild S; Fraterman A; Molnàr D; Veidebaum T; Siani A; Russo P
    Nutr Metab Cardiovasc Dis; 2017 Jun; 27(6):543-551. PubMed ID: 28511904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of adiponectin and low-grade inflammation with the course of metabolic syndrome.
    Ahonen TM; Saltevo JT; Kautiainen HJ; Kumpusalo EA; Vanhala MJ
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):285-91. PubMed ID: 21093230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits and relationship of steps walked per day to cardiometabolic risk factor in Brazilian middle-aged men.
    Cocate PG; de Oliveira A; Hermsdorff HH; Alfenas Rde C; Amorim PR; Longo GZ; Peluzio Mdo C; Faria FR; Natali AJ
    J Sci Med Sport; 2014 May; 17(3):283-7. PubMed ID: 23742850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma adiponectin distribution in a Mediterranean population and its association with cardiovascular risk factors and metabolic syndrome.
    Salas-Salvadó J; Granada M; Bulló M; Corominas A; Casas P; Foz M
    Metabolism; 2007 Nov; 56(11):1486-92. PubMed ID: 17950098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neck circumference as a simple tool for identifying the metabolic syndrome and insulin resistance: results from the Brazilian Metabolic Syndrome Study.
    Stabe C; Vasques AC; Lima MM; Tambascia MA; Pareja JC; Yamanaka A; Geloneze B
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):874-81. PubMed ID: 22804918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J; McQuillan BM; Thompson PL; Beilby JP
    Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and body fat classification in the metabolic syndrome: impact on cardiometabolic risk metabotype.
    Phillips CM; Tierney AC; Perez-Martinez P; Defoort C; Blaak EE; Gjelstad IM; Lopez-Miranda J; Kiec-Klimczak M; Malczewska-Malec M; Drevon CA; Hall W; Lovegrove JA; Karlstrom B; Risérus U; Roche HM
    Obesity (Silver Spring); 2013 Jan; 21(1):E154-61. PubMed ID: 23505198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.